LivzonDx Showcases Blood Bank Total Solutions at ISBT 2026

Time：2026-06-25

The International Society of Blood Transfusion Congress, ISBT 2026, was recently held in Kuala Lumpur, Malaysia. As an important global platform for transfusion medicine and blood safety, the congress brought together transfusion medicine experts, blood service professionals, clinical institutions, and industry partners from around the world to exchange insights on the latest developments in blood safety management, laboratory practice, and transfusion technologies.

LivzonDx participated in the congress with its integrated blood bank solutions, presenting a portfolio that covers key application areas including donor screening, blood grouping, and blood irradiation. The showcase demonstrated LivzonDx’s continued commitment to supporting safer, more efficient, and more reliable blood services.

For donor screening, LivzonDx presented its AffirPrime HIV-1&2/HBV/HCV multiplex NAT solution. Through single-tube multiplex PCR, it enables simultaneous detection of HIV, HBV, and HCV, supporting shorter window periods, reduced risk of missed detection, and improved efficiency in blood bank screening workflows.

For blood grouping, LivzonDx showcased its ERLIA ABO/RhD Blood Grouping Diagnostic Kit. Designed for ABO forward grouping and RhD typing, the product features an intuitive one-step workflow, clear result interpretation, and rapid turnaround. It can deliver results in as little as 1 minute and has demonstrated 99.87% accuracy in real-world settings, providing efficient and reliable support for blood banks, transfusion departments, and clinical laboratories.

LivzonDx also presented the X-RAD 6000/8000 Blood Irradiator. Using X-ray irradiation technology, the system is designed for the irradiation of blood components and supports the prevention of transfusion-associated graft-versus-host disease (TA-GVHD). X-RAD 8000 supports both rapid and batch irradiation modes, while its self-shielded design eliminates the need for additional room protection, making installation and daily operation more convenient for blood stations and hospitals.

During the congress, the LivzonDx team engaged in meaningful discussions with transfusion medicine professionals, blood bank users, and partners from different countries and regions. Topics included blood screening capacity building, laboratory workflow optimization, transfusion safety management, and future opportunities for international collaboration. LivzonDx’s integrated blood bank solutions received strong interest from visitors and industry professionals at the event.

Blood safety is an essential part of public health and clinical care. Moving forward, LivzonDx will continue to focus on blood safety, infectious disease testing, and laboratory automation, providing reliable diagnostic products and integrated solutions for blood banks, healthcare institutions, and public health organizations worldwide.

LivzonDx remains committed to working with global partners to support safer transfusion practices and better healthcare outcomes.